KR20140078851A - Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique - Google Patents

Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique Download PDF

Info

Publication number
KR20140078851A
KR20140078851A KR1020120148041A KR20120148041A KR20140078851A KR 20140078851 A KR20140078851 A KR 20140078851A KR 1020120148041 A KR1020120148041 A KR 1020120148041A KR 20120148041 A KR20120148041 A KR 20120148041A KR 20140078851 A KR20140078851 A KR 20140078851A
Authority
KR
South Korea
Prior art keywords
extract
chlorella
ethanol
solvent
extraction
Prior art date
Application number
KR1020120148041A
Other languages
Korean (ko)
Other versions
KR101428486B1 (en
Inventor
홍주헌
강일준
이재용
이대훈
박혜미
양수진
Original Assignee
대구가톨릭대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대구가톨릭대학교산학협력단 filed Critical 대구가톨릭대학교산학협력단
Priority to KR1020120148041A priority Critical patent/KR101428486B1/en
Publication of KR20140078851A publication Critical patent/KR20140078851A/en
Application granted granted Critical
Publication of KR101428486B1 publication Critical patent/KR101428486B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/68Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9722Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/44Supercritical state
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a method for producing chlorella extract with improved functionalities characterized by extracting chlorella powder using supercritical carbon dioxide as a solvent, the chlorella extract produced by the method and processed food including the chlorella extracts, wherein the chlorella extract of the present invention can provide extracts with improved functionalities such as antioxidant activities, chlorophyll content and anti-cancer effects compared to chlorella extracts produced by existing methods.

Description

초임계 유체 추출법을 이용한 기능성이 증진된 클로렐라 추출물의 제조방법{Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique}TECHNICAL FIELD The present invention relates to a chlorella extract having improved functionality by using a supercritical fluid extraction method,

본 발명은 클로렐라 분말을 초임계 이산화탄소를 용매로 사용하여 추출하는 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법, 상기 방법으로 제조된 클로렐라 추출물 및 상기 클로렐라 추출물을 함유하는 가공식품에 관한 것이다.The present invention relates to a process for producing chlorella extract having enhanced functionality, which comprises extracting chlorella powder with supercritical carbon dioxide as a solvent, a chlorella extract prepared by the process, and a processed food containing the chlorella extract.

최근 생활수준의 향상으로 인한 삶의 질적 향상과 건강에 대한 관심이 높아지고, 건강보조식품의 소비와 기능성 식품에 대한 관심이 높아지면서 건강보조식품의 소비와 기능성 식품에 대한 수요가 증가하고 있다. 생체에서는 호흡과 에너지 생성 등 다양한 생명유지 활동의 결과로 각종 라디칼(radical)을 포함한 다양한 활성 산소종(reactive oxygen species, ROS)이 생성된다. 이러한 활성 산소종은 세포 구성 성분들인 지질이나 단백질, DNA 등을 비가역적으로 파괴함으로써 암이나 각종 염증, 심혈관계 질환 등의 원인으로 작용함은 물론 피부질환이나 노화의 직간접적인 원인으로 작용하게 된다.Recently, as the quality of life has improved and the interest in health has increased due to the improvement of living standards, and the consumption of health supplement foods and interest in functional foods have increased, the demand for health supplement foods and functional foods has increased. In the living body, various reactive oxygen species (ROS) including various radicals are produced as a result of various life sustaining activities such as breathing and energy generation. These reactive oxygen species irreversibly destroy cell components such as lipids, proteins, and DNA, thereby acting as a cause of cancer, inflammation, cardiovascular disease, and the like, as well as directly or indirectly causing skin diseases or aging.

지구 표면의 대부분을 차지하고 있는 호수나 해양에는 풍부하고 다양한 생물자원과 광물자원이 아직도 대부분 미개발 상태로 남아있다. 따라서 현재 이들 자원에 대한 연구개발은 세계 각국에서 활발하게 수행되고 있다. 해조류는 일반 농산 채소류에 비하여 단백질, 지질, 탄수화물 등 일반성분뿐만 아니라 다양한 종류의 필수 미량원소를 풍부하게 함유하고 있으며, 또한 종류에 따라 특이한 생리활성을 나타내는 성분을 함유하고 있어, 성인병과 비만의 예방, 건강식품 등으로 주목받고 있다. 그 중 클로렐라는 광합성에 의하여 성장, 증식하는 직경 2~10 ㎛의 구형 단세포 녹조류로 필수 아미노산 조성이 좋은 고 단백질 식품으로 총 아미노산 함량은 쇠고기에 비하여 월등히 높으며 단백질, 지질, 식이섬유, 비타민류와 무기질에 관하여 다른 식품과 비교할 수 없을 만큼 영양학적으로도 우수하고 엽록소 (chlorophyll a와 b)를 다량 함유하고 있다.Rich and diverse biological and mineral resources are still largely undeveloped in lakes and oceans that occupy most of the surface of the earth. Therefore, research and development on these resources are actively carried out in various countries around the world. Compared with ordinary agricultural vegetables, seaweed contains not only general components such as protein, lipid, and carbohydrate, but also various kinds of essential trace elements. It also contains ingredients showing specific physiological activities according to kinds, , And health food. Among them, chlorella is a spherical unicellular green algae with a diameter of 2 ~ 10 ㎛ which grows and proliferates by photosynthesis. It is a high protein food with an essential amino acid composition. Total amino acid content is much higher than beef, and protein, lipid, dietary fiber, vitamins and minerals Is nutritionally superior to other foods and contains a large amount of chlorophyll a and b.

초임계 유체를 이용한 추출법은 물질의 기상과 액상의 상경계지점인 임계점(critical point) 이상의 압력과 온도를 설정해 줌으로써 액상의 용해력과 기상의 확산계수와 점도의 특성을 지니게 하여 신속한 추출과 선택적 추출이 가능한 방법이다. 또한 초임계 유체는 주로 이산화탄소 혹은 이산화탄소와 미량의 보조용매로 형성되기 때문에 용매추출법에 비해 유해성 용매의 잔존 위험이 없을 뿐만 아니라 상온부근에서 추출 조작이 이루어질 수 있기 때문에 천연물 또는 식품과 같이 열에 민감한 물질의 추출에 유용한 방법이다.Extraction method using supercritical fluid sets the pressure and temperature above the critical point, which is the point of the vapor phase and liquid phase of the material, so that it has the characteristics of liquid phase dissolution power, gas phase diffusion coefficient and viscosity, Method. Since the supercritical fluid is mainly formed of carbon dioxide or a small amount of co-solvent, there is no risk of residual harmful solvent compared with the solvent extraction method. In addition, since the extraction operation can be performed at a room temperature, It is a useful method for extraction.

현재 클로렐라에 추출법에 대한 연구는 열수, 효소, 유기용매 추출법에 한정되어 있고, 클로렐라 초임계 유체 추출에 대한 연구는 아직 미흡한 실정이다.Currently, studies on extraction of chlorella are limited to hydrothermal, enzymatic and organic solvent extraction methods, and research on the extraction of chlorella supercritical fluid is still insufficient.

한국특허등록 제0558382호에는 초임계 유체 추출법을 이용한 은행잎 추출물의 제조방법이 개시되어 있으나, 본 발명의 초임계 유체 추출법을 이용한 기능성이 증진된 클로렐라 추출물의 제조방법과는 상이하다.Korean Patent Registration No. 0558382 discloses a method of preparing a Ginkgo biloba extract using supercritical fluid extraction, but it is different from the method of producing chlorella extract having enhanced functionality using the supercritical fluid extraction method of the present invention.

본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명은 클로렐라를 추출하는 데 있어서, 기존의 유기용매 추출법의 문제점인 인체 유해, 환경 독성, 고비용, 낮은 선택성 등을 해결하고, 새로운 추출, 정제 기술로 각광받고 있는 초임계 유체 기술을 이용하여 클로렐라의 기능성 성분 및 생리활성 효과가 증진된 추출물을 제조하기 위한 추출 방법을 확립하는데 그 목적이 있다.Accordingly, the present invention has been made in view of the above problems, and it is an object of the present invention to solve the problems of the conventional organic solvent extraction method, such as the human body, environmental toxicity, high cost and low selectivity, The present invention aims at establishing an extraction method for producing an extract having enhanced functional components and physiological activity of chlorella using supercritical fluid technology which is attracting attention as a technology.

상기 과제를 해결하기 위해, 본 발명은 클로렐라 분말을 초임계 이산화탄소를 용매로 사용하여 추출하는 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법을 제공한다.In order to solve the above-described problems, the present invention provides a method for producing chlorella extract having enhanced functionality, which comprises extracting chlorella powder with supercritical carbon dioxide as a solvent.

또한, 본 발명은 상기 방법으로 제조된 기능성이 증진된 클로렐라 추출물을 제공한다.The present invention also provides a functionalized chlorella extract prepared by the above method.

또한, 본 발명은 상기 클로렐라 추출물을 함유하는 건강기능식품을 제공한다.The present invention also provides a health functional food containing the chlorella extract.

본 발명의 초임계 유체 추출공정을 통해 제조된 클로렐라 추출물은 기존의 용매 추출물이나 다른 조건으로 제조된 초임계 추출물에 비해 항산화 효과와 위암, 폐암 및 자궁경부암 등에 대한 항암 효과 등의 기능성과 추출물 내에 클로렐라의 유효성분인 엽록소를 가장 많이 함유함으로써, 상기 기능성이 증진된 클로렐라 추출물을 이용하여 식품, 의약품, 화장품 산업 등에 유용하게 이용할 수 있는 효과가 있다.The chlorella extract prepared through the supercritical fluid extraction process of the present invention has antioxidative effect and anticancer effect against gastric cancer, lung cancer and cervical cancer as compared with the conventional solvent extract and supercritical extract prepared under different conditions, It is possible to utilize the chlorella extract with improved functionality to be usefully used in foods, medicines, cosmetics industry, and the like.

또한, 본 발명의 가장 큰 장점은 인체에 무해한 이산화탄소를 용매로 사용하여 추출함으로써, 기존의 유기용매에 의한 추출방법에 비해 환경친화적이고, 기존의 추출법에 비해 공정이 간단하고 추출시간을 줄일 수 있는 이점이 있다.In addition, the greatest advantage of the present invention is that by extracting carbon dioxide, which is harmless to the human body, as a solvent, it is more environmentally friendly than the conventional organic solvent extraction method, and the process is simpler than the conventional extraction method, There is an advantage.

도 1은 본 실험에 사용된 초임계유체 추출장치를 보여준다.
도 2는 클로렐라 추출물의 슈퍼옥사이드 라디칼 소거능(%)을 농도별로 비교한 그래프이다.
도 3은 클로렐라 추출물의 산화질소 생성량을 농도별로 비교한 그래프이다.
도 4는 클로렐라 추출물의 농도별 처리에 따른 암세포(A549: 폐암세포, HeLa: 자궁경부암세포, SNU719: 위암세포) 생존율을 비교한 그래프이다.
도 2 내지 4의 50% ethanol: 클로렐라 50% 에탄올 추출물, 94% ethanol: 클로렐라 94% 에탄올 추출물, Supercritical fluid: 클로렐라 초임계 추출물을 의미한다.
Figure 1 shows the supercritical fluid extraction device used in this experiment.
FIG. 2 is a graph showing the concentration of superoxide radical scavenging ability (%) of chlorella extract by concentration.
FIG. 3 is a graph comparing the amount of nitric oxide produced in chlorella extract by concentration. FIG.
FIG. 4 is a graph comparing survival rates of cancer cells (A549: lung cancer cells, HeLa: cervical cancer cells, SNU719: stomach cancer cells) according to the concentration of chlorella extract.
50% ethanol: chlorella 50% ethanol extract, 94% ethanol: chlorella 94% ethanol extract, Supercritical fluid: chlorella supercritical extract shown in FIGS.

본 발명의 목적을 달성하기 위하여, 본 발명은 클로렐라 분말을 초임계 이산화탄소를 용매로 사용하여 추출하는 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법을 제공한다.In order to accomplish the object of the present invention, the present invention provides a method for producing chlorella extract having enhanced functionality, which comprises extracting chlorella powder with supercritical carbon dioxide as a solvent.

본 발명의 클로렐라 추출물의 제조방법에서, 상기 추출은 바람직하게는 45~55℃의 온도 및 180~220 bar의 압력에서 35~45분 동안 실시할 수 있으며, 더욱 바람직하게는 50℃의 온도 및 200 bar의 압력에서 40분 동안 실시할 수 있다. 상기 조건으로 클로렐라를 추출하는 것이 기존의 유기용매를 이용한 추출이나 다른 조건에서 초임계 추출하는 것에 비해 추출물의 항산화 활성 및 항암 효과가 증진되고 추출물 내에 클로렐라의 기능성 성분인 엽록소 함량을 증진시킬 수 있었다.In the process for preparing chlorella extract of the present invention, the extraction is preferably carried out at a temperature of 45 to 55 ° C and a pressure of 180 to 220 bar for 35 to 45 minutes, more preferably at a temperature of 50 ° C and at 200 bar pressure for 40 minutes. The extraction of chlorella under the above conditions can enhance the antioxidative and anticancer effects of the extract and enhance the chlorophyll content of chlorella in the extract, compared with the conventional extraction with an organic solvent or supercritical extraction under other conditions.

또한, 본 발명의 클로렐라 추출물의 제조방법에서, 상기 추출시 추출물의 기능성을 더욱 증진시키기 위해 추가로 보조용매를 사용할 수 있는데, 상기 보조용매는 에탄올, 이소프로판올, 에틸아세테이트 또는 테트라하이드로퓨란일 수 있으며, 바람직하게는 에탄올일 수 있으나, 이에 제한되지 않는다.In addition, in the method for preparing chlorella extract of the present invention, an auxiliary solvent may be further used to further enhance the functionality of the extract at the time of extraction. The auxiliary solvent may be ethanol, isopropanol, ethyl acetate or tetrahydrofuran, Preferably ethanol, but is not limited thereto.

또한, 본 발명의 클로렐라 추출물의 제조방법에서, 상기 기능성은 항산화 활성, 엽록소 함량 또는 항암 효과일 수 있으며, 상기 암은 위암, 폐암 또는 자궁경부암일 수 있으나, 이에 제한되지 않는다.In addition, in the method for producing chlorella extract of the present invention, the functionalities may be antioxidant activity, chlorophyll content or anticancer effect, and the cancer may be gastric cancer, lung cancer or cervical cancer, but is not limited thereto.

본 발명의 클로렐라 추출물의 제조방법은 구체적으로는 클로렐라 분말을 초임계 이산화탄소를 용매로 사용하여 용매를 유속 18~22 mL/분으로 공급하고 추가로 에탄올을 보조용매로 사용하여, 45~55℃의 온도 및 180~220 bar의 압력에서 35~45분 동안 추출하여 제조할 수 있으며, 더욱 구체적으로는 클로렐라 분말을 초임계 이산화탄소를 용매로 사용하여 용매를 유속 20 mL/분으로 공급하고 추가로 에탄올을 보조용매로 사용하여, 50℃의 온도 및 200 bar의 압력에서 40분 동안 추출하여 제조할 수 있다.The method for preparing chlorella extract of the present invention is characterized in that chlorella powder is prepared by supplying supercritical carbon dioxide as a solvent, supplying the solvent at a flow rate of 18 to 22 mL / min and further using ethanol as an auxiliary solvent at 45 to 55 ° C Temperature and pressures of 180 to 220 bar for 35 to 45 minutes. More specifically, chlorella powder can be prepared by supplying supercritical carbon dioxide as a solvent at a flow rate of 20 mL / min and further adding ethanol Using as an auxiliary solvent and extracting at a temperature of 50 ° C and a pressure of 200 bar for 40 minutes.

본 발명은 또한, 상기 방법으로 제조된 기능성이 증진된 클로렐라 추출물을 제공한다.The present invention also provides a functionalized chlorella extract prepared by the above method.

본 발명은 또한, 상기 클로렐라 추출물을 함유하는 가공식품을 제공한다. 상기 가공식품의 종류에는 특별한 제한은 없다. 상기 클로렐라 추출물을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 가공식품을 모두 포함한다.
The present invention also provides a processed food containing the chlorella extract. There is no particular limitation on the kind of the processed food. Examples of the food to which the chlorella extract can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, various soups, drinks, tea, , An alcoholic beverage and a vitamin complex, and includes all processed foods in a conventional sense.

이하, 본 발명의 실시예를 들어 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, embodiments of the present invention will be described in detail. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.

1. 실험재료1. Experimental material

실험재료로 사용한 클로렐라(Chlorella sp.) 원말 분말은 대상(주) 군산공장(한국)으로부터 제공받아 본 실험에 사용하였으며, 시료는 -20℃ 이하의 암소에 보관하면서 추출용 시료로 사용하였다.
Chlorella sp. Powder was used for this experiment. The sample was stored in a cow below -20 ℃ and used as a sample for extraction.

2. 시료추출방법2. Sample extraction method

(1) 용매추출(1) Solvent extraction

시료와 추출 용매비를 1:20으로 하여 50% 에탄올과 94% 에탄올을 각각 첨가하여 50℃에서 4시간 동안 환류냉각(CA-1112, Eyela Co., Japan) 추출하였다. 추출 후 불순물을 제거하기 위해 Whatman No.2 여과지(Whatman International Ltd, England)를 이용하여 여과하였다. 여과된 용액은 감압농축기(Model N-1N, Eyela Co., Tokyo, Japan)를 사용하여 감압 농축한 뒤, 동결건조(FreeZone 2.5, Labconco Co, USA)하여 -70℃ 이하의 암소에 보관하면서 분석용 시료로 사용하였다.
50% ethanol and 94% ethanol were added to each sample at a ratio of 1:20, and the mixture was refluxed for 4 hours at 50 ° C (CA-1112, Eyela Co., Japan). After extraction, it was filtered using a Whatman No.2 filter paper (Whatman International Ltd, England) to remove impurities. The filtered solution was concentrated under reduced pressure using a vacuum concentrator (Model N-1N, Eyela Co., Tokyo, Japan), and lyophilized (FreeZone 2.5, Labconco Co, USA) Was used as a sample.

(2) 초임계 추출(2) supercritical extraction

본 실험에 사용된 초임계유체 추출장치는 도 1에서 보는 바와 같이 쿨링 헤드(Cooling head)가 장착된 HPLC 펌프(pu-980, JASCO Co., Japan)와 보조용매를 공급하는 또 다른 HPLC 펌프, 추출조(Extraction vessel)가 설치되어 있는 Air-driven oven(CO-965 column oven, JASCO Co., Japan), 수집용기에 용출액(Effluent)이 포집될 수 있는 전자식 역압력 조절기(880-01, JASCO Co., Japan)로 나누어져 있다. 한편 각 추출 공정의 변수인 압력과 온도는 역압력 조절기(Back-pressure regulator)와 압축공기를 원동력으로 하는 오븐(Air-driven oven)에 의해 각각 조절할 수 있도록 제조되어 있다.As shown in FIG. 1, the supercritical fluid extraction apparatus used in this experiment was an HPLC pump (pu-980, JASCO Co., Japan) equipped with a cooling head and another HPLC pump for supplying an auxiliary solvent, An air-driven oven (CO-965 column oven, JASCO Co., Japan) equipped with an extraction vessel, an electronic back pressure regulator (880-01, JASCO Co., Co., Japan). The pressure and temperature of each extraction process are adjusted by a back-pressure regulator and an air-driven oven.

시료 5 g을 추출용 용기(vessel)에 충진하여 압력 200 bar, 온도 50℃에서 CO2 유속 20 mL/분으로 40분간 추출하였다. 보조용매 에탄올을 첨가하여 추출하였다. 추출한 추출물은 추출물 대비 2배의 물(H2O)을 가해 회전 진공 농축기(Model N-1N, Eyela Co., Tokyo, Japan)로 최대한 감압 농축한 뒤, 동결건조(Labconcon Co., USA)하여 -70℃ 이하의 암소에 보관하면서 분석용 시료로 사용하였다.
5 g of the sample was filled in an extraction vessel and extracted at a pressure of 200 bar and a temperature of 50 ° C for 40 minutes at a CO 2 flow rate of 20 mL / min. Extraction was performed by adding ethanol as a co-solvent. The extracted extract was concentrated under reduced pressure with a rotary vacuum concentrator (Model N-1N, Eyela Co., Tokyo, Japan) twice by water (H 2 O) And stored in a dark room at -70 ° C or lower.

3. 실험방법3. Experimental Method

(1) 전자공여능 측정(1) Electron donating ability measurement

추출물의 전자공여능은 1,1-diphenyl-2-pycrylhydrazyl(DPPH)의 환원력을 이용하여 측정하였다. 즉, DPPH 시약 12 mg을 무수 에탄올(absolute ethanol) 100 mL에 용해한 후 물 100 mL를 첨가하여 DPPH 용액의 흡광도를 517 nm에서 약 1.6으로 조정한 후, 추출물 0.5 mL에 DPPH 용액 5.0 mL를 혼합하여 실온에서 15분간 방치 한 후 분광광도계(Ultraspec 2100pro, Amersham Co., Sweden)로 흡광도를 측정하고 아래와 같이 계산하였다.The electron donating ability of the extract was measured by the reducing power of 1,1-diphenyl-2-pycrylhydrazyl (DPPH). That is, 12 mg of DPPH reagent was dissolved in absolute ethanol (100 mL), and 100 mL of water was added to adjust the absorbance of the DPPH solution to about 1.6 at 517 nm. Then, 0.5 mL of the extract was mixed with 5.0 mL of the DPPH solution After incubation at room temperature for 15 minutes, absorbance was measured with a spectrophotometer (Ultraspec 2100pro, Amersham Co., Sweden) and calculated as follows.

전자공여능(%) = (1 - 시료첨가군의 흡광도/무첨가군의 흡광도) × 100
Electron donating ability (%) = (1 - absorbance of sample addition group / absorbance of no addition group) x 100

(2) ORAC(Oxygen Radical Absorbancity Capacity) 측정 (2) Measurement of ORAC (Oxygen Radical Absorbency Capacity)

항산화 활성은 Talcott ST와 Lee JH가 항산화 활성 측정에 사용한 ORAC(Oxygen Radical Absorbance Capacity) 분석법을 이용하였다. 본 실험에서 검액 및 표준액의 농도별 희석과 실험용 시료의 제조에는 중성 인산 완충액(61.6:38.9 v/v, 0.75 M K2HPO₄및 0.75 M NaH2PO4)을 사용하였다. 검량 곡선을 작성하기 위하여 항산화 활성 비교 표준액으로 트롤록스(Water soluble analogue of vitamin E, 6-hydroxy-2,5,7,8-tetramethlychroman-2-carboxylic acid, Aldrich Chem, Inc., USA)를 인산 완충액을 가해 각각 0.0, 1.65, 3.125, 6.25, 12.5, 25.0, 50.0 μM 농도로 희석하고 fluorescent stock(Sigma, St, Louis, MO, USA) 10 ㎕를 인산 완충액 50 mL에 용해하여 제조하였고 측정기기는 fluorescent microplate reader(Infinite M200 PRO, Tecan Co., Austria)를 사용하여, 485 nm에서 전자가 여기상태가 되고 538 nm에서 방출되게 조절하여 본 실험에 적용하였다.
Antioxidant activity was measured by ORAC (Oxygen Radical Absorbance Capacity) method, which was used by Talcott ST and Lee JH to measure antioxidant activity. In this experiment, Neutral Phosphate Buffer (61.6: 38.9 v / v, 0.75 MK 2 HPO4 and 0.75 M NaH 2 PO 4 ) was used for the dilution of the test solution and standard solution and preparation of the experimental sample. In order to prepare a calibration curve, a water soluble analogue of vitamin E (6-hydroxy-2,5,7,8-tetramethlychroman-2-carboxylic acid, Aldrich Chem, Inc., USA) (Sigma, St. Louis, Mo., USA) was dissolved in phosphate buffer (50 mL), and the concentration of the fluorescent stock (Sigma, St. Louis, Mo., USA) Using a fluorescent microplate reader (Infinite M200 PRO, Tecan Co., Austria), the electrons were excited at 485 nm and emitted at 538 nm.

(3) FRAP(Ferric-reducing antioxidant potential) 측정(3) Ferric-reducing antioxidant potential (FRAP) measurement

FRAP법에 의한 항산화 활성은 300 mM 아세테이트 버퍼(acetate buffer, pH 3.6), 40 mM HCl에 용해한 10 mM TPTZ(2,4,6-tripyridyl-s-triazine) 용액 및 20 mM FeCl3·6H20를 각각 10:1:1(v/v/v)의 비율로 혼합하여 37℃의 수욕상에서 가온한 것을 FRAP 기질액으로 사용하였다. 96 웰 플레이트(well plate)에 시료액 25 ㎕, FRAP 기질액 175 ㎕를 차례대로 혼합하여 37℃에서 4분간 반응시킨 후 590 nm에서 흡광도를 측정하였으며, FeSO4·7H20를 표준물질로 하여 얻은 표준 검량선으로부터 계산하였다.
The antioxidant activity by FRAP method was measured by using a 300 mM acetate buffer (pH 3.6), a 10 mM TPTZ (2,4,6-tripyridyl-s-triazine) solution dissolved in 40 mM HCl and a 20 mM FeCl 3 .6H 2 O Were mixed at a ratio of 10: 1: 1 (v / v / v), and the mixture was heated in a 37 ° C water bath. 25 μl of the sample solution and 175 μl of the FRAP substrate were mixed in a 96-well plate, and reacted at 37 ° C. for 4 minutes. The absorbance at 590 nm was measured, and FeSO 4 · 7H 2 O was used as a standard Calculated from the standard calibration curve obtained.

(4) 총 엽록소 함량 측정(4) Total chlorophyll content measurement

총 엽록소 함량 측정은 건조분말 0.05 g을 증류수 10 mL에 녹인 후 30분간 초음파 처리를 하였다. 현탁액 2 mL를 취하여 차광한 원심분리관에 넣고 알카리성 피리딘(pyridine) 용액 5 mL를 가한 후 60℃ 수욕 상에서 15분간 초음파 처리를 하였다. 그 다음 3분간 4℃에서 3000 rpm으로 원심분리한 후 상층액을 10 mL 갈색 m-플라스크에 옮긴 후 남아 있는 잔사는 반복 처리하여 최종 10 mL가 되도록 하였다. 알카리성 피리딘 용액을 대조액으로 하여 액층 1 cm, 파장 419 nm와 454 nm에서 흡광도를 측정하였다.Total chlorophyll content was measured by dissolving 0.05 g of dry powder in 10 mL of distilled water and sonication for 30 minutes. 2 mL of the suspension was placed in a shaded centrifuge tube, 5 mL of an alkaline pyridine solution was added, and the mixture was ultrasonicated for 15 minutes in a water bath at 60 ° C. After centrifugation at 3000 rpm at 4 ° C for 3 minutes, the supernatant was transferred to a 10 mL brown m-flask, and the remaining residue was repeatedly treated to a final volume of 10 mL. Absorbance was measured at a wavelength of 419 nm and a wavelength of 454 nm using a solution of alkaline pyridine as a reference solution.

총 엽록소(mg/100 g)=C / S × 100Total chlorophyll (mg / 100 g) = C / S x 100

C: 엽록소(mg/L)= 8.970 × (7.19 E419 nm + 3.33 E454 nm)C: chlorophyll (mg / L) = 8.970 × (7.19 E419 nm + 3.33 E454 nm)

S: 시료채취 mg수/ 5S: Number of samples collected / 5

E419 nm :419 nm의 흡광도E419 nm: Absorbance at 419 nm

E454 nm :454 nm의 흡광도
E454 nm: absorbance at 454 nm

(5) 슈퍼옥사이드 라디칼(Superoxide radical) 소거 활성 측정(5) Superoxide radical scavenging activity measurement

슈퍼옥사이드 라디칼(Superoxide radical) 소거활성은 희석한 시료 20 ㎕에 62 μM NBT(nitro blue tetrazolium)와 98 μM β-nicotinamide adenine dinucleotide(NADH)를 함유한 20 mM 트리스 용액(pH 8.0) 800 ㎕를 혼합한 다음, 20 mM 트리스(Tris) 용액 80 ㎕와 33 μM phenazine methosulfate(PMS) 100 ㎕를 각각 첨가하였다. 즉, 비효소적으로 PMS/NADH로 유발된 슈퍼옥사이드 라디칼(superoxide radical)은 포르마잔(formazan)을 측정하기 위해 560 nm에서 10분 동안 반응물의 흡광도를 측정하였고 아래 식으로 계산하였다. Superoxide radical scavenging activity was determined by mixing 800 μL of a 20 mM Tris solution (pH 8.0) containing 62 μM NBT (nitro blue tetrazolium) and 98 μM β-nicotinamide adenine dinucleotide (NADH) in 20 μL of the diluted sample Then, 80 μl of a 20 mM Tris solution and 100 μl of 33 μM phenazine methosulfate (PMS) were added, respectively. In other words, the superoxide radicals induced by PMS / NADH nonenzymatically were measured by measuring the absorbance of the reactants at 560 nm for 10 minutes to measure formazan and the following equation.

슈퍼옥사이드 라디칼 소거능(Superoxide radical scavenging ability) = [(AB)/A]×100Superoxide radical scavenging ability = [(AB) / A] x 100

A: 샘플을 첨가하지 않은 흡광도A: absorbance without addition of sample

B: 샘플 첨가 흡광도
B: absorbance of sample added

(6) 세포주 배양(6) Cell culture

실험에 이용한 세포주는 인간 위암세포(SNU719), 인간 폐암세포(A549), 인간 자궁경부암세포(HeLa), 마우스 대식세포 Raw 264.7 세포를 사용하였다. SNU719, A549, HeLa 세포주와 Raw 264.7 세포주는 DMEM 배지를 이용하여 10% FBS(Fetal bovine serum), 페니실린-스트렙토마이신(Penicillin-streptomycin)을 첨가하여 사용하였다. 세포는 모두 37℃, 5% CO2 인큐베이터에 적응시켜 각각 배양시켰다.
Human gastric cancer cells (SNU719), human lung cancer cells (A549), human cervical cancer cells (HeLa) and mouse macrophages Raw 264.7 cells were used for the experiment. SNU719, A549, HeLa cell line and Raw 264.7 cell line were supplemented with 10% FBS (Fetal bovine serum) and penicillin-streptomycin using DMEM medium. Cells are both 37 ℃, 5% CO 2 And incubated in an incubator.

(7) 산화질소(nitric oxide) 저해활성 측정(7) Measurement of inhibitory activity of nitric oxide

Raw 264.7 세포로부터 생성되는 산화질소의 양을 그리스(Griess) 시약을 이용하여 다음과 같이 측정하였다. 즉 96 웰 플레이트에 2×104 cell/mL로 각각 100 ㎕씩 첨가하여 37℃, 5% CO2 인큐베이터에서 24시간 배양하였다. 배양한 후 DMSO로 녹인 다양한 농도의 추출물 및 LPS(1 ㎍/mL)를 처리하여 24시간 배양하였다. 배양이 끝나면 상등액 50 ㎕에 동량의 그리스(Griess) 시약을 혼합하여 10분간 암반응시킨 후 540 nm에서 흡광도를 측정하였다. NO의 농도는 아질산 나트륨(sodium nitrite)의 농도별 표준곡선을 이용하여 계산하였다.
The amount of nitric oxide produced from Raw 264.7 cells was measured using a Griess reagent as follows. That is, 100 μl each of 2 × 10 4 cells / mL was added to each well of a 96-well plate, and incubated at 37 ° C. in 5% CO 2 And cultured in an incubator for 24 hours. After culturing, various concentrations of extracts and LPS (1 μg / mL) dissolved in DMSO were treated and cultured for 24 hours. After incubation, 50 ㎕ of supernatant was mixed with the same amount of Griess reagent, incubated for 10 min, and absorbance was measured at 540 nm. The concentration of NO was calculated using the standard curve for the concentration of sodium nitrite.

(8) 항암활성 측정(8) Measurement of anticancer activity

배양된 암 세포주를 2×104 cell/mL로 96 웰 플레이트에 각각 100 ㎕씩 첨가하여 37℃, 5% CO2 배양기에서 24시간 배양하고 DMSO에 녹인 클로렐라 추출물을 농도별로 처리한 후 48시간 동안 배양하였다. 배양 후 PBS 완충용액에 녹인 MTT(5 mg/mL) 용액을 각 웰(well)에 10 ㎕씩 첨가하고 다시 4시간 동안 CO2 인큐베이터에서 배양하여 MTT가 환원되도록 하였다. 배양종료 후 생성된 포르마잔(formazan) 결정이 흐트러지지 않게 배양액을 완전히 제거하고 제거된 각 웰(well)에 100 ㎕씩의 DMSO를 가하여 10분간 반응시켜 포르마잔(formazan) 결정을 용해한 후 ELISA reader를 이용하여 540 nm에서 흡광도를 측정하였다. 추출물을 처리하지 않은 세포를 대조군으로 하여 상대적인 세포생존율로 나타내었다.
The cultured cancer cell lines, 2 × 10 4 cell / mL was added to each 96-well plate by 100 ㎕ to 37 ℃, 5% CO 2 After culturing for 24 hours in an incubator, the chlorella extract dissolved in DMSO was treated for each concentration and cultured for 48 hours. After the cultivation was dissolved in PBS buffer solution, MTT (5 mg / mL) solution for each well (well) 10 ㎕ added and again four hours by the CO 2 MTT was reduced by incubation in an incubator. Formazan crystals formed after the completion of incubation were completely removed so that the culture solution was completely removed. 100 μl of DMSO was added to each of the removed wells to react for 10 minutes to dissolve the formazan crystals, and the ELISA reader And the absorbance at 540 nm was measured. Cells not treated with the extract were expressed as relative cell viability as a control.

(9) 통계 처리(9) Statistical processing

실험결과는 SPSS 12.0 package로 통계처리 하였으며, 각 시료에 대한 평균±표준편차로 나타내었다. 각 시료에 대한 유의성 검정은 분산분석을 한 후 p<0.05 수준에서 Duncan's multiple test에 따라 분석하였다.
Experimental results were statistically analyzed with SPSS 12.0 package and expressed as mean ± standard deviation for each sample. The significance test for each sample was analyzed by Duncan's multiple test at p <0.05 after analysis of variance.

실시예Example 1: 클로렐라 추출물의 추출 수율 1: Extraction yield of chlorella extract

추출방법에 따른 추출 수율은 초임계유체 추출, 94% 에탄올 및 50% 에탄올이 각각 5.2%, 3.4% 및 8.1%로 나타나 50% 에탄올이 가장 양호하였다. 이러한 결과는 극성의 성질로 인해 목적으로 하는 클로로필 성분 이외에 가용성 고형분이 많이 추출된 까닭이라고 사료된다.Extraction yields of supercritical fluid extraction, 94% ethanol and 50% ethanol were 5.2%, 3.4% and 8.1%, respectively, and 50% ethanol was the best. These results suggest that soluble solids were extracted in addition to the desired chlorophyll content due to the nature of the polarity.

클로렐라 추출물의 추출 수율Extraction yield of chlorella extract 추출물 종류Extract Type 수율1 )(%, w/w)Yield 1 ) (%, w / w) 클로렐라 초임계 추출물Chlorella supercritical extract 5.25.2 클로렐라 94% 에탄올 추출물Chlorella 94% Ethanol Extract 3.43.4 클로렐라 50% 에탄올 추출물Chlorella 50% Ethanol Extract 8.18.1

1)수율(%) = 추출물의 고형분(g)/생 시료(건조 무게) × 100
1) Yield (%) = solid content (g) of extract / raw material (dry weight) x 100

실시예Example 2: 클로렐라 추출물의  2: of the chlorella extract 전자공여능Electron donating ability  And ORACORAC

전자공여능은 활성 라디칼에 전자를 공여하고 식품 중의 지방질 산화를 억제하는 목적으로 사용되며, 인체 내에서는 활성 라디칼에 의한 노화를 억제시키는 작용으로 이용되고 있으며 라디칼 소거작용은 인체의 질병과 노화를 방지하는데 대단히 중요한 역할을 한다. 클로렐라의 추출방법에 따른 추출물의 전자공여능을 표 2에 나타내었다. 클로렐라 추출물의 전자공여능은 초임계 추출조건에서 30.15%로 가장 우수하였으며 50% 에탄올 추출물이 7.95%로 가장 낮게 나타났다.Electron donating ability is used to donate electrons to active radicals and to inhibit lipid oxidation in foods. In the human body, it is used to inhibit aging by active radicals. Radical scavenging action prevents human diseases and aging It plays a very important role. The electron donating ability of the extract according to the extraction method of chlorella is shown in Table 2. The electron donating ability of chlorella extract was the highest at 30.15% under the supercritical extraction condition and the lowest at 50% ethanol extract was 7.95%.

본 연구에서 사용한 ORAC 방법은 라디칼 연쇄반응(radical chain reaction)의 가장 핵심적인 단계인 수소전자 전달과 연관하여 AAPH(2,2'-azobis-2-methyl-propanimidamide, dihydrochloride)에 의해 생성된 자유라디칼에 대한 항산화 물질의 소거 능력, 즉 라디칼 연쇄 파괴 항산화능(radical chain breaking antioxidant capacity)을 측정함으로써 식품 내에 존재하는 소수성(hydrophobic) 성분과 친수성(hydrophilic) 성분 모두에 반응하기 때문에 응용범위가 넓은 장점을 가지고 있다. 클로렐라의 추출방법에 따른 추출물의 ORAC 측정 결과, 초임계 추출물 및 94% 에탄올 추출물이 각각 134.18 μmoles TE/g와 120.90 μmoles TE/g이었고 50% 에탄올 추출물이 115.74 μmoles TE/g로 분석되어 초임계 추출물이 가장 우수한 것을 확인할 수 있었다.The ORAC method used in this study was based on the free radicals generated by AAPH (2,2'-azobis-2-methyl-propanimidamide, dihydrochloride) in association with hydrogen electron transfer, which is the most critical step of the radical chain reaction (Ie, radical chain breaking antioxidant capacity) by measuring the antioxidant's ability to remove antioxidants, ie, hydrophobic and hydrophilic components, Have. As a result of ORAC measurement of the extracts according to the extraction method of chlorella, supercritical extract and 94% ethanol extract were 134.18 μmoles TE / g and 120.90 μmoles TE / g respectively, and 50% ethanol extract was 115.74 μmoles TE / g, Was the most excellent.

클로렐라 추출물의 전자공여능 및 ORACElectron donating ability of chlorella extract and ORAC 추출물 종류Extract Type 전자공여능(%)Electron donating ability (%) ORAC(μmoles TE/g)ORAC (μmoles TE / g) 클로렐라 초임계 추출물Chlorella supercritical extract 30.15±0.64a 30.15 + 0.64 a 134.18±4.97a 134.18 ± 4.97 a 클로렐라 94% 에탄올 추출물Chlorella 94% Ethanol Extract 12.21±0.94b 12.21 + - 0.94 b 120.90±0.28b 120.90 ± 0.28 b 클로렐라 50% 에탄올 추출물Chlorella 50% Ethanol Extract 7.95±0.90c 7.95 + - 0.90 c 115.74±6.32b 115.74 ± 6.32 b

상기 데이터는 3 반복 실험에 의한 평균±표준편차를 의미함The data represent the mean ± standard deviation from three replicate experiments

a-c 각각의 열 내의 다른 윗첨자는 유의차가 있음을 의미함(p<0.05)
The other superscripts in each column of ac mean that there is a significant difference ( p <0.05)

실시예Example 3: 클로렐라 추출물의 총 엽록소 함량  3: Total chlorophyll content of chlorella extract

추출방법에 따른 추출물의 총 엽록소 함량은 표 3과 같다. 총 엽록소 함량은 초임계 유체 추출물이 8,064.41 ㎎/100 g으로 가장 많이 추출되었고, 94% 및 50% 에탄올 추출물이 각각 5,362.11 ㎎/100 g과 549.30 ㎎/100 g으로 분석되었다. 따라서 클로렐라의 주요 기능성분인 클로로필 추출에는 초임계 유체 추출공정이 효율적임을 확인하였다. 기존의 시럽 타입(syrup type) 클로렐라 제품의 엽록소 함량이 30.8 ㎎/100 g, 츄어블 타입(chewable type) 클로렐라 제품의 엽록소 함량이 123.7 mg/100 g이라고 보고되었는데, 클로로필의 다양한 식품 및 화장품산업의 소재로 활용하기 위해 초임계 유체 추출방법이 활용 가능함을 확인하였다.The total chlorophyll content of the extract according to the extraction method is shown in Table 3. The total chlorophyll content of the supercritical fluid extract was 8,064.41 ㎎ / 100 g and the 94% and 50% ethanol extracts were 5,362.11 ㎎ / 100 g and 549.30 ㎎ / 100 g, respectively. Therefore, it was confirmed that the supercritical fluid extraction process was effective for chlorophyll extraction, which is a main functional ingredient of chlorella. The chlorophyll content of the syrup type chlorella product was reported to be 30.8 ㎎ / 100 g and the chlorophyll content of the chewable type chlorella product was 123.7 mg / 100 g. The chlorophyll content of the various food and cosmetic industries It is confirmed that the supercritical fluid extraction method can be utilized.

클로렐라 추출물의 총 엽록소 함량Total chlorophyll content of chlorella extract 추출물 종류Extract Type 총 엽록소 함량(mg/100 g) Total chlorophyll content (mg / 100 g) 클로렐라 초임계 추출물Chlorella supercritical extract 8,064.41±94.40a 8,064.41 ± 94.40 a 클로렐라 94% 에탄올 추출물Chlorella 94% Ethanol Extract 5,362.11±140.41b 5,362.11 ± 140.41 b 클로렐라 50% 에탄올 추출물Chlorella 50% Ethanol Extract 549.30±22.57c 549.30 ± 22.57 c

상기 데이터는 3 반복 실험에 의한 평균±표준편차를 의미함The data represent the mean ± standard deviation from three replicate experiments

a-c 각각의 열 내의 다른 윗첨자는 유의차가 있음을 의미함(p<0.05)
The other superscripts in each column of ac mean that there is a significant difference ( p <0.05)

실시예Example 4: 클로렐라 추출물의  4: Chlorella extract FRAPFRAP 에 의한 항산화 활성Antioxidant activity by

FRAP(Ferric reducing antioxidant power)법에 의한 항산화 활성은 산성 pH영역에서 ferric tripyridyltriazine(Fe3 +-TPTZ) 복합체가 환원성 물질에 의해 청색의 ferrous tripyridyltriazine(Fe2 +-TPTZ)으로 환원되는 원리를 이용한 것으로 대부분의 항산화제가 환원력을 가지고 있다는 점에 착안하여 고안된 방법이다. 추출방법에 따른 클로렐라 추출물의 FRAP 결과는 표 4와 같다.The antioxidative activity of ferric reducing antioxidant power (FRAP) is based on the principle that ferric tripyridyltriazine (Fe 3 + -TPTZ) complex is reduced to ferrous tripyridyltriazine (Fe 2 + -TPTZ) Most of the antioxidants are designed with a focus on the fact that they have a reducing power. The FRAP results of chlorella extract according to the extraction method are shown in Table 4.

모든 추출조건에서 농도 의존적으로 활성이 증가하였으나 50% 에탄올 추출물 250~500 ㎍/mL 농도에서 47~46.70 μM로 유의적인 차이는 보이지 않았다. 1,000 ㎍/mL 농도에서 FRAP 항산화 활성은 통계적으로 초임계 추출물이 397.17 μM로 가장 높았으며, 94% 에탄올 추출물 및 50% 에탄올 추출물이 각각 220.53 μM, 80.30 μM 순으로 나타났다. 이는 양성 대조군으로 사용한 아스코르브산(ascorbic acid)과 FRAP법에 의한 항산화 활성은 산화반응의 촉매제로 작용하는 금속이온을 환원시키는 효력을 의미하는데 시료의 환원력은 전자공여를 통한 라디칼의 소거활성과도 관련이 높아 전자공여능과 유사한 실험결과가 나타난 것으로 사료된다.The activity was increased in a concentration - dependent manner at all extraction conditions. However, no significant difference was observed between 47 and 46.70 μM at 50 ~ 500 ㎍ / mL concentration of 50% ethanol extract. At the concentration of 1,000 ㎍ / mL, FRAP antioxidant activity was statistically the highest at 397.17 μM in supercritical extract and 220.53 μM and 80.30 μM in 94% ethanol extract and 50% ethanol extract, respectively. This is because the ascorbic acid and the antioxidative activity of FRAP method used as a positive control means the effect of reducing the metal ion acting as a catalyst of the oxidation reaction. The reducing power of the sample is also related to the scavenging activity of the radical through electron donation The results of this study are similar to those of electron donating ability.

클로렐라 추추물의 FRAP에 의한 항산화 활성(FeSO4 eq μM)Antioxidant activity of FRAP of chlorella extract (FeSO 4 eq μM) 추출물 종류Extract Type Concentration (㎍/mL)Concentration (/ / mL) 100100 250250 500500 10001000 초임계 추출물Supercritical extract 71.90±6.84a 71.90 + - 6.84 a 123.06±8.02b 123.06 + - 8.02 b 217.23±7.97c 217.23 ± 7.97 c 397.17±4.41d 397.17 + - 4.41 d 94% 에탄올 추출물94% ethanol extract 78.77±2.45a 78.77 ± 2.45 a 81.06±8.41a 81.06 ± 8.41 a 131.46±10.36b 131.46 ± 10.36 b 220.53±7.72c 220.53 + - 7.72 c 50% 에탄올 추출물50% ethanol extract 17.67±1.52a 17.67 ± 1.52 a 47.00±1.73b 47.00 ± 1.73 b 46.70±1.92b 46.70 ± 1.92 b 80.30±2.89c 80.30 ± 2.89 c ascorbic acidascorbic acid 993.23±9.67a 993.23 ± 9.67 a 1710.44±15.01b 1710.44 + 15.01 b 1767.20±10.01c 1767.20 ± 10.01 c 1774.58±23.41c 1774.58 + - 23.41 c

a-d 각각의 열 내의 다른 윗첨자는 유의차가 있음을 의미함(p<0.05)
ad The other superscripts in each column indicate a significant difference ( p <0.05)

실시예Example 5: 클로렐라 추출물의  5: Chlorella extract 슈퍼옥사이드Superoxide 라디칼( Radical ( NonNon -- enzymaticenzymatic systemsystem : NADH-PMS) 소거활성: NADH-PMS) scavenging activity

비효소적인 방법인 PMS/NADH로 유발된 슈퍼옥사이드 라디칼 생성계인 경우 NBT는 자주색의 포르마잔(formazan)으로 환원된다. 시료 내 슈퍼옥사이드 라디칼(superoxide radical) 소거 활성이 존재하는 경우, 시료첨가에 의해 포르마잔(formazan)의 생성이 억제되며 흡광도가 감소하게 된다. 추출방법에 따른 클로렐라 추출의 농도별 슈퍼옥사이드 라디칼(superoxide radical) 소거 활성은 도 2와 같다. 추출 조건별로 농도가 증가할수록 소거활성도 증가하였으나 농도 간의 소거활성 차이가 크게 나타나지 않았다. 초임계 유체 추출물 1,000 ㎍/mL에서 66.76% 소거활성을 나타내었으며 94% 에탄올 추출물과 50% 에탄올 추출물에서는 추출물 간의 소거활성에서 큰 차이를 나타내지 않았다.
In the case of the superoxide radical generation system induced by the nonenzymatic PMS / NADH, NBT is reduced to purple formazan. In the presence of the superoxide radical scavenging activity in the sample, the addition of the sample inhibits the formation of formazan and decreases the absorbance. The superoxide radical scavenging activity of each concentration of chlorella extract according to the extraction method is shown in FIG. As the concentration increased, the scavenging activity was increased but the scavenging activity was not significantly different. The supernatant fluid extract showed 66.76% scavenging activity at 1,000 ㎍ / mL. The 94% ethanol extract and the 50% ethanol extract showed no significant difference in the scavenging activity between the extracts.

실시예Example 6: 클로렐라 추출물의 산화질소( 6: Nitric oxide of chlorella extract ( NONO ) 생성량) Production amount

NO 생성량은 RAW 264.7 세포의 배양액 중에 NO의 함량을 측정하는 것으로 L-아르기닌(L-arginine)에 NO 합성효소(NO Synthetase)가 작용하여 생성되며, 생성된 NO는 암세포의 증식을 억제하는 것으로 알려져 있다. 클로렐라 추출물을 세포의 생존율에 영향을 미치지 않는 농도인 1,000 ㎍/mL 농도까지 처리한 후 NO 생성에 미치는 영향을 조사한 결과는 도 3과 같다. LPS 처리군의 경우 NO 생성량은 27.08 μM였으며 초임계 추출물의 경우 250 ㎍/mL에서부터 농도의존적으로 생성량이 증가하였으며 1,000 ㎍/mL에서 26.87 μM로 NO 생성량을 나타내 LPS와 비교해 보았을 때 99.24%의 높은 면역증강 활성을 나타내는 것을 알 수 있었다. 94% 에탄올 추출물과 50% 에탄올 추출물은 1,000 ㎍/mL에서 각각 11.97 μM와 12.31 μM의 산화질소(nitric oxide) 생성량을 보여주었다.
The amount of NO produced is determined by measuring the content of NO in the culture medium of RAW 264.7 cells, which is produced by the action of NO synthetase on L-arginine, and NO produced is known to inhibit the proliferation of cancer cells have. The results of investigating the effect of chlorella extract on the production of NO after treatment of 1,000 ㎍ / mL concentration, which does not affect cell survival rate, are shown in FIG. In the LPS-treated group, the NO production was 27.08 μM, and the supercritical extract increased the concentration-dependent production from 250 μg / mL. The NO production was increased from 1,000 μg / mL to 26.87 μM, which was 99.24% Enhancing activity. 94% ethanol extract and 50% ethanol extract showed 11.97 μM and 12.31 μM nitric oxide production at 1,000 ㎍ / mL, respectively.

실시예Example 7: 클로렐라 추출물의 암세포 생육억제 효과( 7: Inhibitory Effect of Chlorella Extract on the Growth of Cancer Cells MTTMTT AssayAssay ))

추출방법에 따른 클로렐라 추출물을 A549, HeLa, SNU719 등 3종의 암세포에 처리하여 세포 생존율을 살펴본 결과는 도 4와 같다. A549 세포의 경우 초임계 유체 추출물에서 100 ㎍/mL 농도에서는 저해율이 크게 나타나지 않았지만, 250~1,000 ㎍/mL에서 49.32~56.04%의 높은 암세포주 생육 억제효과를 나타내었다. 94% 에탄올 추출물의 경우 1,000 ㎍/mL에서 13.79%로 약한 억제효과를 나타내었으며 다른 농도에서도 거의 효과가 미비하였다. 50% 에탄올 추출물의 경우 250~1,000 ㎍/mL에서 20.83~23.2%의 암세포주 생육 억제효과를 나타내 초임계 유체 추출물의 암세포 생육 억제효과가 가장 높음을 확인하였다.The results of examining the cell viability by treating chlorella extract according to the extraction method with three types of cancer cells such as A549, HeLa and SNU719 are shown in FIG. The inhibitory effect of A549 cells on supercritical fluid extract was not significantly increased at 100 ㎍ / mL concentration, but showed a high inhibitory effect on cancer cell growth of 49.32 ~ 56.04% at 250 ~ 1,000 ㎍ / mL. The 94% ethanol extract showed a mild inhibitory effect of 13.79% at 1,000 ㎍ / mL and almost no effect at other concentrations. The inhibitory effect of 50% ethanol extract on the growth of cancer cells was observed at 250 ~ 1,000 ㎍ / mL at 20.83 ~ 23.2%, and supercritical fluid extract showed the highest inhibitory effect on cancer cell growth.

HeLa 세포의 경우도 초임계 유체 추출물의 100~1,000 ㎍/mL 농도에서 55.68~57.05%의 암세포주 생육 억제효과를 나타내어 94% 에탄올 추출물과 50% 에탄올 추출물에 비해 가장 높았다. 94% 에탄올 추출물에서 암세포 증식억제 효과가 나타나지 않았으며 50% 에탄올 추출물 1,000 ㎍/mL에서 41.04% 암세포 성장 억제 효과를 나타내었다.In the case of HeLa cells, the growth inhibition effect of cancer cells was 55.68 ~ 57.05% at 100 ~ 1,000 ㎍ / mL concentration of supercritical fluid extract, which was the highest in the case of 94% ethanol extract and 50% ethanol extract. The 94% ethanol extract showed no inhibitory effect on the growth of cancer cells and showed a 41.04% inhibitory effect on cancer cell growth at 1,000 ㎍ / mL of 50% ethanol extract.

SNU719 세포에서는 1,000 ㎍/mL에서 초임계 유체 추출물 및 50% 에탄올 추출물이 각각 52.95, 30.32%로 나타나 농도 의존적으로 암세포주 생육 억제효과를 나타내었고 94% 에탄올 추출물은 암세포 증식억제가 미비하였다.In SNU719 cells, the supercritical fluid extract and the 50% ethanol extract at the concentration of 1,000 ㎍ / mL were 52.95 and 30.32%, respectively. The inhibitory effect of the ethanol extract on the growth of cancer cells was dose dependent.

Claims (7)

클로렐라 분말을 초임계 이산화탄소를 용매로 사용하여 45~55℃의 온도 및 180~220 bar의 압력에서 35~45분 동안 추출하여 제조하는 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법.Wherein the chlorella powder is prepared by extracting the chlorella powder with supercritical carbon dioxide as a solvent at a temperature of 45 to 55 ° C and a pressure of 180 to 220 bar for 35 to 45 minutes. 제1항에 있어서, 상기 추출시 추가로 보조용매를 사용하며, 보조용매는 에탄올, 이소프로판올, 에틸아세테이트 또는 테트라하이드로퓨란인 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법.The method according to claim 1, wherein the auxiliary solvent is further used in the extraction, and the auxiliary solvent is ethanol, isopropanol, ethyl acetate or tetrahydrofuran. 제1항에 있어서, 상기 기능성은 항산화 활성, 엽록소 함량 또는 항암 효과인 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법.The method according to claim 1, wherein the functionalities are antioxidant activity, chlorophyll content, or anticancer effect. 제3항에 있어서, 상기 암은 위암, 폐암 또는 자궁경부암인 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법.[Claim 5] The method according to claim 3, wherein the cancer is gastric cancer, lung cancer or cervical cancer. 제1항에 있어서, 클로렐라 분말을 초임계 이산화탄소를 용매로 사용하여 용매를 유속 18~22 mL/분으로 공급하고 추가로 에탄올을 보조용매로 사용하여, 45~55℃의 온도 및 180~220 bar의 압력에서 35~45분 동안 추출하여 제조하는 것을 특징으로 하는 기능성이 증진된 클로렐라 추출물의 제조방법.The method of claim 1, wherein the chlorella powder is prepared by using supercritical carbon dioxide as a solvent, supplying the solvent at a flow rate of 18 to 22 mL / min and further using ethanol as an auxiliary solvent at a temperature of 45 to 55 DEG C and a pressure of 180 to 220 bar At a pressure of 50-45 &lt; 0 &gt; C for 35-45 minutes. 제1항 내지 제5항 중 어느 한 항의 방법으로 제조된 기능성이 증진된 클로렐라 추출물.A functional enhanced chlorella extract prepared by the method of any one of claims 1 to 5. 제6항의 클로렐라 추출물을 함유하는 가공식품.A processed food containing the chlorella extract of claim 6.
KR1020120148041A 2012-12-18 2012-12-18 Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique KR101428486B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120148041A KR101428486B1 (en) 2012-12-18 2012-12-18 Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120148041A KR101428486B1 (en) 2012-12-18 2012-12-18 Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique

Publications (2)

Publication Number Publication Date
KR20140078851A true KR20140078851A (en) 2014-06-26
KR101428486B1 KR101428486B1 (en) 2014-08-12

Family

ID=51130217

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120148041A KR101428486B1 (en) 2012-12-18 2012-12-18 Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique

Country Status (1)

Country Link
KR (1) KR101428486B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020009422A1 (en) * 2018-07-06 2020-01-09 주식회사 에이블 Method for preparing chlorophyll-containing extract

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101771897B1 (en) 2015-08-18 2017-09-04 한국생명공학연구원 Pharmaceutical composition for the treatment of cancers or inhibition of metastasis containing extract of chlorella sp.
US20210401801A1 (en) 2018-11-06 2021-12-30 Abl Co.,Ltd Method for long-term storage of chlorophyll-containing extract

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100558382B1 (en) * 2002-04-03 2006-03-10 그린텍이십일 주식회사 A method for production of extract from ginkgo biloba l. by supercritical fluid extraction technique
KR101244213B1 (en) * 2011-04-07 2013-03-14 강원대학교산학협력단 Cultivation method of chlorella and extraction method of beta carotene from chlorella

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020009422A1 (en) * 2018-07-06 2020-01-09 주식회사 에이블 Method for preparing chlorophyll-containing extract

Also Published As

Publication number Publication date
KR101428486B1 (en) 2014-08-12

Similar Documents

Publication Publication Date Title
Flieger et al. Antioxidants: Classification, natural sources, activity/capacity measurements, and usefulness for the synthesis of nanoparticles
Vitas et al. Chemical composition and biological activity of novel types of kombucha beverages with yarrow
Suhartono et al. Total flavonoid and antioxidant activity of some selected medicinal plants in South Kalimantan of Indonesian
Prasad et al. Effects of high pressure or ultrasonic treatment on extraction yield and antioxidant activity of pericarp tissues of longan fruit
Jing et al. Antioxidant activity, antitumor effect, and antiaging property of proanthocyanidins extracted from Kunlun Chrysanthemum flowers
Que et al. In vitro and vivo antioxidant activities of daylily flowers and the involvement of phenolic compounds
Li et al. Antioxidant activity of peach blossom extracts
CH692837A5 (en) A pharmaceutical composition for use in foodstuffs, dietetic or medicinal product suitable to improve the oral absorption of the polyphenols and particularly of resveratrol present in grapes and in its p
KR101936294B1 (en) Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata
Zhao et al. In-vitro free radical scavenging activities of anthocyanins from three berries
Michelon et al. Araucaria angustifolia: A potential nutraceutical with antioxidant and antimutagenic activities
Ejelonu et al. Antioxidant profile of four selected wild edible mushrooms in Nigeria
KR101428486B1 (en) Method for producing chlorella extract with improved functionality using supercritical fluid extraction technique
KR20180040534A (en) Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill.
Ko et al. Antioxidant and antiradical activities of Wu Ling Shen in a cell free system
KR101793208B1 (en) A compostion comprising Cotoneaster horizontalis Decne extract having anti-oxidation or anti-inflammation activity
Krishna et al. Exploring the therapeutic potential of edible Pleurotus mushroom species for oxidative stress and diabetes management
CN105853342B (en) Purposes of the polyphenol extract as tyrosinase inhibitor a kind of in spirulina
Jha et al. In vitro evaluation of free radical scavenging activity of Pistia stratiotes
Demirbas Antimicrobial and catalytic activity of citrus fruits peels mediated nano-flowers
Luo et al. Antioxidant activities of various fractions extracted from Astragalus
KR101611881B1 (en) Method for producing Phellinus linteus mycelium pressurized extract with increased antioxidant and whitening activity cultured in Mori ramulus medium
KR101389471B1 (en) Method for producing chlorella powder with increased chlorophyll content and antioxidant activity
Celik et al. Evaluation of antioxidant, antiradicalic and antimicrobial activities of kernel date (Fructus dactylus)
KR20170077980A (en) Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant